BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30081883)

  • 1. Lymphatic vessel density as a prognostic indicator in Asian NSCLC patients: a meta-analysis.
    Xu S; Yang J; Xu S; Zhu Y; Zhang C; Liu L; Liu H; Dong Y; Teng Z; Xing X
    BMC Pulm Med; 2018 Aug; 18(1):128. PubMed ID: 30081883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic microvessel density as a prognostic factor in non-small cell lung carcinoma: a meta-analysis of the literature.
    Wang J; Li K; Wang B; Bi J
    Mol Biol Rep; 2012 May; 39(5):5331-8. PubMed ID: 22167333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and prognostic significance of podoplanin-positive lymphatic vessel density in non-small cell lung carcinoma].
    Wang Y; Sun JG; Ye MF; Chen ZT
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):758-61. PubMed ID: 17327058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation Analysis Among the Level of IL-35, Microvessel Density, Lymphatic Vessel Density, and Prognosis in Non-Small Cell Lung Cancer.
    Zhang T; Nie J; Liu X; Han Z; Ding N; Gai K; Liu Y; Chen L; Guo C
    Clin Transl Sci; 2021 Jan; 14(1):389-394. PubMed ID: 33048433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.
    Wang J; Wang B; Zhao W; Guo Y; Chen H; Chu H; Liang X; Bi J
    PLoS One; 2012; 7(12):e52704. PubMed ID: 23285161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer.
    Jin S; Zhu W; Shi Q; Zhang Z; Guo R
    Med Oncol; 2012 Dec; 29(5):3157-61. PubMed ID: 22528515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node ratio is a prognostic factor for non-small cell lung cancer.
    Sun G; Xue L; Wang M; Zhao X
    Oncotarget; 2015 Oct; 6(32):33912-8. PubMed ID: 26393881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
    Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
    Wang XL; Fang JP; Tang RY; Chen XM
    BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.
    Sun JG; Wang Y; Chen ZT; Zhuo WL; Zhu B; Liao RX; Zhang SX
    J Exp Clin Cancer Res; 2009 Feb; 28(1):21. PubMed ID: 19216806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of lymphatic vessel invasion in stage I non-small cell lung cancer patients.
    Ma KF; Chu XY; Liu Y
    Genet Mol Res; 2015 Mar; 14(1):1819-27. PubMed ID: 25867327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of lymphatic vessel density in oral squamous cell carcinoma.
    Chen J; Zhang F; Hua M; Song X; Liu S; Dong Z
    Life Sci; 2021 Jan; 265():118746. PubMed ID: 33181177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis.
    Chen E; Zeng Z; Bai B; Zhu J; Song Z
    Oncotarget; 2016 Aug; 7(35):56526-56539. PubMed ID: 27489355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung.
    Iwakiri S; Nagai S; Katakura H; Takenaka K; Date H; Wada H; Tanaka F
    Ann Surg Oncol; 2009 Jun; 16(6):1678-85. PubMed ID: 19330380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of lymphangiogenesis and lymphatic vessel invasion in non-small cell lung cancer].
    Hu Z; Wang W; Zhang J; Mao F; Shen-Tu Y
    Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):656-62. PubMed ID: 23164352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.
    Wang J; Chen J; Chen X; Wang B; Li K; Bi J
    PLoS One; 2011; 6(12):e28844. PubMed ID: 22194927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship among the expression of lymphatic vessel density, microvessel density, carcinoembryonic antigenic mRNA, KAI1, and Kiss-1, and prognosis in patients with non-small cell lung cancer].
    Wang G; Wang Z; Li C; Wang P; Chai D; Cheng Z
    Zhongguo Fei Ai Za Zhi; 2012 Jun; 15(6):348-54. PubMed ID: 22681921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis reveals prognostic role of programmed death ligand-1 in Asian patients with non-small cell lung cancer.
    Hu XY; Zhang W; Hu Y; Zhang Y; Gong R; Liang JY; Liu L
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):313-320. PubMed ID: 27376797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of D2-40 in non-small cell lung cancer.
    Min KH; Park SJ; Lee KS; Hwang SH; Kim SR; Moon H; Han HJ; Chung MJ; Lee YC
    Lung; 2011 Feb; 189(1):57-63. PubMed ID: 21107593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.